RxDoctor Payments DataLook up a doctor →

Robert Jenders

Internal Medicine · Torrance, CANPI 1629006796

Payments from drug & device makers

$5,927,915in general payments, 2019–2025

Across 1,443 payments — averaging $4108.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Eli Lilly$2.3M
  • Boehringer Ingelheim International GmbH$800K
  • Sanofi Pasteur Inc.$689K
  • Boehringer Ingelheim$541K
  • Regeneron$495K
  • Genentech, Inc.$364K
  • plus $711K from 13 others
$158,314in research payments, 2019–2025

Across 28 payments — averaging $5654.06 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AbbVie$131K
  • Eli Lilly$27K

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Eli Lilly91$2,327,855
Boehringer Ingelheim International GmbH307$799,871
Sanofi Pasteur Inc.25$689,291
Boehringer Ingelheim29$541,188
Regeneron738$494,703
Genentech, Inc.30$363,568
Akcea Therapeutics, Inc.19$133,022
Novartis4$110,863
Novo Nordisk AS47$98,284
AbbVie21$65,043
Currax Pharmaceuticals LLC17$57,804
AstraZeneca6$54,344
Corcept Therapeutics9$45,069
GSK11$43,216
Biohaven Pharmaceutical Holding Company Ltd.39$41,496
Modernatx, Inc.15$36,866
Boehringer Ingelheim RCV GmbH & Co KG30$10,135
Madrigal Pharmaceuticals3$8,115
Vertex2$7,181

How this compares

$5,927,915 in reported general payments places this provider in the 95th percentile of 13,581 internal medicine providers in California.

See all internal medicine providers in California →

Other internal medicine in Torrance

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →